Simcere Pharmaceutical Group Limited (HKG: 2096)

Simcere Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 13, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17,653	17,611	30,914	23,628	23,347	-
Market Cap Growth	-29.50%	-43.03%	30.83%	1.20%	-	-
Enterprise Value	15,639	16,205	29,371	23,209	26,834	-
Last Close Price	7.08	6.53	11.02	8.37	8.22	-
PE Ratio	-	21.96	27.34	11.80	24.74	-
Forward PE	17.31	11.82	29.04	26.63	17.99	-
PS Ratio	2.68	2.42	4.32	3.85	4.36	-
PB Ratio	2.42	2.21	3.83	2.98	3.68	-
P/TBV Ratio	2.33	2.51	4.16	3.10	3.89	-
P/FCF Ratio	26.82	-	27.04	-	-	-
P/OCF Ratio	12.35	105.83	20.19	-	203.24	-
PEG Ratio	1.12	1.12	1.12	1.12	-	-
EV/Sales Ratio	2.30	2.23	4.11	3.78	5.01	-
EV/EBITDA Ratio	11.76	15.90	31.86	44.76	29.79	-
EV/EBIT Ratio	15.42	20.69	42.85	81.03	37.66	-
EV/FCF Ratio	23.76	-	25.69	-	-	-
Debt / Equity Ratio	0.17	0.20	0.21	0.25	0.62	1.99
Debt / EBITDA Ratio	0.96	1.43	1.72	3.50	4.10	2.26
Debt / FCF Ratio	1.93	-	1.49	-	-	11.09
Asset Turnover	0.52	0.61	0.60	0.47	0.51	0.77
Inventory Turnover	1.84	2.84	4.01	3.59	2.94	3.14
Quick Ratio	1.82	1.75	1.69	1.51	1.48	0.66
Current Ratio	2.10	2.10	1.84	1.63	1.85	0.85
Return on Equity (ROE)	-13.81%	9.94%	13.62%	25.41%	19.49%	65.91%
Return on Assets (ROA)	4.79%	4.11%	3.62%	1.38%	4.23%	11.02%
Return on Capital (ROIC)	6.39%	5.13%	4.52%	1.74%	5.74%	17.39%
Earnings Yield	-8.15%	4.47%	3.40%	7.83%	3.41%	-
FCF Yield	4.53%	-2.08%	3.70%	-2.14%	-1.30%	-
Dividend Yield	2.47%	2.70%	1.64%	2.20%	2.17%	-
Payout Ratio	0.00%	58.65%	42.04%	25.96%	-	90.88%
Buyback Yield / Dilution	1.94%	0.45%	-0.35%	-9.14%	-2.03%	-
Total Shareholder Return	4.41%	3.15%	1.30%	-6.94%	0.14%	-

Source: S&P Capital IQ. Standard template. Financial Sources.